ACTRN12618001348246尚未招募4 期
Evaluation of the efficacy and safety of Pyronaridine-Artesunate (Pyramax™) with low-dose Primaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Salavanh province, Lao PDR
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 7 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
4 期
Efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria and chloroquine for the treatment of uncomplicated Plasmodium vivax malaria in Binh Phuoc, Gia Lai and Phu Yen provinces, Viet Nam in 2021.Patients infected Plasmodium falciparumPatients infected Plasmodium vivaxInfection - Other infectious diseasesACTRN12621001743853World Health Organization42
尚未招募
4 期
Efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in Gia Lai province, Viet Nam in 2022.Patients infected with plasmodium falciparum.Infection - Other infectious diseasesACTRN12622001407785World Health Organization42
已完成
3 期
EFFICACY AND SAFETY OF PYRONARIDINE-ARTESUNATE (PYRAMAX) FOR THE TREATMENT OF FALCIPARUM MALARIA IN AFRICAN PREGNANT WOMEMalariaPACTR202011812241529niversity of Sciences Techniques and Technologies of Bamako1,875
尚未招募
不适用
Therapeutic efficacy of pyronaridine-artesunate for Plasmodium vivax in MyanmarmalariaACTRN12618001621202Ministry of Health and Sports140
招募中
不适用
Therapeutic efficacy studies of pyronaridine-artesunate combination for the treatment of uncomplicated Plasmodium falciparum malaria in MyanmarmalariaFeverACTRN12618001620213Ministry of Health and Sports140